Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Molecules Biolabs is an India-based biotechnology and nutraceutical innovation company specializing in advanced drug and nutrient delivery systems. Founded by Dr. Sreeraj Gopi, the company is a pioneer in liposomal and molecular complexation technologies, notably its patented Metazome™ dry liposomal technology and OMICS™ platform. These technologies are designed to significantly enhance the bioavailability, stability, and absorption of bioactive compounds, botanical extracts, and vitamins. Molecules Biolabs manufactures and exports a diverse portfolio of clinically validated health supplements, including its highly bioavailable berberine formulation (BerbiQ™) and palmitoylethanolamide formulation (PEA.IN™), to over 50 countries globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Molecules Biolabs.